Gallbladder & Bile Routes

Bile acids are made from cholesterol in the liver and are commonly conjugated with glycine or taurine before secretion. At intestinal pH much of this material is present as bile salts. Their amphipathic chemistry helps lipid products interact with the watery intestinal environment; pancreatic enzymes perform the chemical digestion.

Recovery occurs after luminal use. A mixed micelle does not enter an enterocyte as an intact chylomicron. Lipid products and bile acids can leave the luminal mixture by different mechanisms and ultimately take different routes. Follow the existing intestinal absorption lesson for lipid assembly and lymphatic entry.

Mechanism evidence: Ticho et al. · Intestinal absorption of bile acids · OpenStax · Liver, pancreas and gallbladder

The apical sodium-dependent bile acid transporter, ASBT (SLC10A2), is prominent in mature ileal absorptive cells. Its position at the brush-border membrane lets it take up bile acids from intestinal contents together with sodium. A transporter crosses a cell membrane; it is not a duct running through the whole tissue.

ASBT uses an existing electrochemical gradient. The Na⁺/K⁺-ATPase on the basolateral membrane consumes ATP to maintain low intracellular sodium. The energy-consuming pump and the sodium-coupled uptake carrier therefore occupy different functional steps. The drawing locates membrane domains, not verified individual protein structures.

Mechanism evidence: Dawson et al. · Bile acid transporters

After apical entry, bile acids are handled within the living enterocyte. Ileal bile-acid-binding protein contributes to intracellular handling; the cytoplasm is not an empty pipe. At the lateral and basal surfaces, the two-subunit OSTα/β system provides an important route of export.

OSTα/β is a facilitated transporter, rather than another sodium-driven ASBT or an ATP-burning pump. Transport direction depends on the prevailing conditions; net export is the normal absorptive context shown here. Export into the tissue compartment is followed by vascular exchange and downstream portal drainage.

Mechanism evidence: Dawson et al. · Bile acid transporters · Ticho et al. · Intestinal absorption of bile acids · Landrier et al. · FXR and human OST genes

The epithelial basal boundary, lamina propria and endothelial lining separate intestinal contents from blood. Absorbed bile acids traverse this tissue relationship before returning through intestinal veins toward the hepatic portal system. The small illustrated mucosal vessel is not itself the entire portal vein.

Many long-chain dietary fats instead enter lymph as chylomicrons after cellular reassembly. Bile-acid recovery should not be drawn into that lacteal route merely because bile assisted fat absorption. The retained liver and intestine chapters continue the regional blood and lymph pathways.

Mechanism evidence: Ticho et al. · Intestinal absorption of bile acids · OpenStax · Liver, pancreas and gallbladder

At the sinusoidal surface, uptake systems including sodium-dependent NTCP and organic anion transporting polypeptides (OATPs) bring returning bile acids into hepatocytes. Their substrate contributions differ. These names identify molecular transport mechanisms; a coloured patch in an atlas cell is not evidence that a particular transporter has been imaged.

Canalicular BSEP uses ATP-dependent export to secrete bile salts toward the small bile space between adjacent hepatocytes. This is a different surface from the blood-facing uptake side. Canalicular bile continues into the biliary tree; blood remains in the sinusoidal circulation.

Mechanism evidence: Dawson et al. · Bile acid transporters · Ticho et al. · Intestinal absorption of bile acids

Bile acids also carry information. Activation of the nuclear receptor FXR in ileal cells can promote human FGF19 production. The resulting endocrine signal travels through blood rather than through a new duct between intestine and liver. FXR signalling can also regulate transport-related genes, including OSTα and OSTβ.

Human ileal explants exposed to bile acids showed increased FGF19 transcripts and secreted protein. This supports a responsive human tissue mechanism; the experimental concentrations and incubation times are not a timetable or diagnostic threshold for an individual after a meal. FGF19 expression is not exclusive to the ileum in every tissue or context.

Mechanism evidence: Zhang et al. · Human ileal explants and FGF19 · Landrier et al. · FXR and human OST genes · Human tissue-derived organoids · enterohepatic signalling

At the liver, FGF19 interacts with FGFR4 and the co-receptor β-Klotho. Downstream signalling can suppress CYP7A1 expression, reducing a major entry step in the classical pathway of new bile-acid synthesis from cholesterol. Returning material and a returning hormonal message are related, but they are not the same cargo.

Hepatic FXR-related mechanisms and wider metabolic inputs also regulate the pool. A human tissue-derived organoid system has linked intestinal bile-acid stimulation and functional FGF19 secretion with a hepatic response. Such controlled models illuminate the connection without reproducing every feature of an intact human circulation.

Mechanism evidence: β-Klotho and endocrine FGF signalling · Song et al. · FGF19 signalling in human hepatocytes · Human tissue-derived organoids · enterohepatic signalling

Water and electrolyte recovery from gallbladder contents leaves a more concentrated stored solution. Ileal recovery retrieves bile acids from the intestinal lumen after delivery. Both use polarised epithelia, but the organ, material and physiological purpose differ.

The reservoir is a side branch, not an obligatory checkpoint for every drop of liver bile. Reused bile salts can enter the continuing biliary supply whether or not that portion is temporarily stored. Keep formation, storage, concentration, delivery and recycling as connected but distinct processes.

Mechanism evidence: OpenStax · Liver, pancreas and gallbladder · Ticho et al. · Intestinal absorption of bile acids

Nutrients in the intestine stimulate hormonal and neural responses that coordinate bile delivery. In the existing meal-response lesson, CCK participates in gallbladder contraction and terminal outlet relaxation. Secretin has a different role in bicarbonate-rich ductal secretion.

The FXR–FGF19 connection taught here concerns feedback on bile-acid synthesis. It should not replace the meal-related motor explanation. These are selected dominant teaching roles, not a claim that each hormone has only one effect or that all responses occur simultaneously.

Mechanism evidence: OpenStax · Liver, pancreas and gallbladder · Zhang et al. · Human ileal explants and FGF19 · β-Klotho and endocrine FGF signalling

Enterohepatic cycling conserves much of the available bile-acid pool, but recovery is not perfect. Some material escapes absorption and is lost in faeces. New hepatic synthesis replenishes this loss while signalling helps coordinate production with the returning pool.

The balance varies with bile-acid species, intestinal transit and physiological context. No fixed recovery percentage, daily cycle count or universal synthesis rate is assigned by these states. This lesson explains normal control, not a test of whether a person has malabsorption.

Mechanism evidence: Ticho et al. · Intestinal absorption of bile acids · Dawson et al. · Bile acid transporters

The intestine contains a mixture of bile-acid species. Microbial deconjugation and other transformations change this mixture, including formation of secondary bile acids. Chemical form affects membrane permeability and which transport mechanisms can contribute.

Passive absorption can occur outside the main active ileal route, particularly for suitable unconjugated species. Therefore “all bile acids return only through ASBT in the terminal ileum” is too absolute. The illustrated ASBT–OST path explains a major organised recovery mechanism without depicting every microbial or passive route.

Mechanism evidence: Ticho et al. · Intestinal absorption of bile acids

Human FGF19 and the related mouse FGF15 are not interchangeable labels for the same experiment. The linked human explant, human cell and organoid studies answer different questions; animal pathway experiments add evidence but cannot supply a universal human response size.

The new intestinal image and retained gallbladder and hepatocyte images are original generated teaching illustrations, not acquired microscopy. They support visible compartment relationships. Receptor conformation, transporter counts, enzyme location and precise ultrastructure have not been certified from their appearance. The functional claims come from the accompanying sources.

Mechanism evidence: Zhang et al. · Human ileal explants and FGF19 · Song et al. · FGF19 signalling in human hepatocytes · Human tissue-derived organoids · enterohepatic signalling · β-Klotho and endocrine FGF signalling